412 related articles for article (PubMed ID: 10846073)
21. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
Sample J; Young L; Martin B; Chatman T; Kieff E; Rickinson A; Kieff E
J Virol; 1990 Sep; 64(9):4084-92. PubMed ID: 2166806
[TBL] [Abstract][Full Text] [Related]
22. Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey.
Ohara N; Hayashi K; Teramoto N; Oka T; Fujimoto K; Yoshikawa Y; Castanos-Velez E; Biberfeld P; Akagi T
Intervirology; 2000; 43(2):102-6. PubMed ID: 10971128
[TBL] [Abstract][Full Text] [Related]
23. Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene.
Ohashi M; Orlova N; Quink C; Wang F
J Virol; 2011 Feb; 85(3):1330-9. PubMed ID: 21084476
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
25. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
Zimber-Strobl U; Strobl LJ; Meitinger C; Hinrichs R; Sakai T; Furukawa T; Honjo T; Bornkamm GW
EMBO J; 1994 Oct; 13(20):4973-82. PubMed ID: 7957063
[TBL] [Abstract][Full Text] [Related]
27. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
[TBL] [Abstract][Full Text] [Related]
28. Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model.
Rivailler P; Jiang H; Cho YG; Quink C; Wang F
J Virol; 2002 Jan; 76(1):421-6. PubMed ID: 11739708
[TBL] [Abstract][Full Text] [Related]
29. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
Zhao B; Marshall DR; Sample CE
J Virol; 1996 Jul; 70(7):4228-36. PubMed ID: 8676443
[TBL] [Abstract][Full Text] [Related]
30. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
[TBL] [Abstract][Full Text] [Related]
31. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).
Fuentes-Pananá EM; Swaminathan S; Ling PD
J Virol; 1999 Jan; 73(1):826-33. PubMed ID: 9847397
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function.
McCann EM; Kelly GL; Rickinson AB; Bell AI
J Gen Virol; 2001 Dec; 82(Pt 12):3067-3079. PubMed ID: 11714985
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
[TBL] [Abstract][Full Text] [Related]
35. Structure and function of the Epstein-Barr virus transcription factor, EBNA 3C.
West MJ
Curr Protein Pept Sci; 2006 Apr; 7(2):123-36. PubMed ID: 16611138
[TBL] [Abstract][Full Text] [Related]
36. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
Tomkinson B; Kieff E
J Virol; 1992 Feb; 66(2):780-9. PubMed ID: 1309912
[TBL] [Abstract][Full Text] [Related]
37. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.
Walling DM; Perkins AG; Webster-Cyriaque J; Resnick L; Raab-Traub N
J Virol; 1994 Dec; 68(12):7918-26. PubMed ID: 7966582
[TBL] [Abstract][Full Text] [Related]
38. Comparative sequence analyses of Epstein-Barr virus nuclear antigen-2 and -3B genes of a fresh Epstein-Barr virus-2 isolate.
Inoue N; Kikuta H; Yanagi K
Intervirology; 1992; 33(4):180-6. PubMed ID: 1339417
[TBL] [Abstract][Full Text] [Related]
39. Immortalizing genes of Epstein-Barr virus.
Middleton T; Gahn TA; Martin JM; Sugden B
Adv Virus Res; 1991; 40():19-55. PubMed ID: 1659776
[TBL] [Abstract][Full Text] [Related]
40. Multiple functions within the Epstein-Barr virus EBNA-3A protein.
Cludts I; Farrell PJ
J Virol; 1998 Mar; 72(3):1862-9. PubMed ID: 9499037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
